Overview of Immunohistochemistry (IHC): Global Markets 2019-2022
Press Release – 28
Jan 2019
Research
and Development News
--
.
.
Latest
Update
"Immunohistochemistry (IHC): Global Markets to 2022"
with Industries Survey | Global Current Growth and Future.
'
'
Immunohistochemistry (IHC) is an umbrella term
which combines immunological, biochemical and anatomical techniques
to image and localize discrete components in tissues with the help of
antibodiesantigen interaction. The use of IHC helps in the
documentation and visualization of the high-resolution distribution
of cellular components and localization of the antigens of the cells
within their proper histological context. The unique properties of
IHC testing to precisely localize the antigens, identify the cell
type and the tumor, has leveraged its wide adoption in diagnosis,
drug development and biological research. IHC tests are employed as a
confirmatory procedure or a primary tool for the diagnosis of various
diseases including cancer, cardiovascular, infectious and other
diseases.
'
'
The author
reached out to many industry contacts, including Chris La Placa, who
is a histotechnologist at BIO SB Inc. Chris has many years of
hands-on experience, so it is instructive that he says Quote: I agree
that the value of the IHC industry is growing and will continue to
grow in the coming years. Many pathologists have previously used more
basic tissue stains to identify entire structures within human
tissue, but IHC is an advantage as it can identify individual
proteins. Its application in diagnosing infectious diseases such as
syphilis and tuberculosis is also growing in popularity. My company
distributes primary antibodies with specificity for bacteria such as
H. pylori, T. pallidum, T. gondii, and P. jirovecii (among many
others), and these are some of our top sellers. Additionally, we
manufacture and sell anchorage dependent cell lines embedded and
mounted to a slide that can be stained by IHC. These can be used as
controls for validation of patient tissues and are of great interest
to pathologists around the world.
Continuous technology and methodological improvements adds value to this type of field especially, where small details and time savings make can make a big difference. For Peter Rauch an MD at Candor Bioscience GMBH we asked which immunoassay solution is the most widely adopted immunoassay in their operating region?
Quote: For us it is the ELISA market, where we sell most of our products, including the wide range of commercial diagnostic ELISA. Understanding regional variations can be an effective way to optimize business approaches in a fast changing landscape.
Continuous technology and methodological improvements adds value to this type of field especially, where small details and time savings make can make a big difference. For Peter Rauch an MD at Candor Bioscience GMBH we asked which immunoassay solution is the most widely adopted immunoassay in their operating region?
Quote: For us it is the ELISA market, where we sell most of our products, including the wide range of commercial diagnostic ELISA. Understanding regional variations can be an effective way to optimize business approaches in a fast changing landscape.
– For
Other Requirement and Enquiry_
https://www.researchmoz.us/enquiry.php?type=E&repid=1854820
'
'
The global
Immunohistochemistry market is projected to rise at a CAGR of xx
during the forecast period of 2017 through 2022. In 2022, total
revenues are expected to reach more than xx,registering an increment
from xx in 2017.
The report provides an analysis based on each market segment which includes products, applications and end users. The product segment is further sub-segmented into IHC antibodies, reagents, kits and equipment. The antibodies held the largest market share of xx in 2017 in terms of revenue followed by reagents, equipment and kits. By 2022, total revenue from the antibodies segment is expected toreach more than xx. Whereas, the reagents segment is estimated to rise at the highest CAGR of xx through 2022. Total revenue from the reagents segment is expected to reach xx million by 2022."
"Report Scope
The scope of this market report is widely characterized by products that include antibodies, equipment, kits and reagents. The total market revenue is restricted to the revenues obtained from the sales of the products required to perform IHC testing successfully. This report covers the different applications of immunohistochemistry in drugs and diagnostics.
Report Includes
- 56 data tables and 65 additional tables
- An overview of the global markets and expected consumption for immunohistochemistry (IHC) technologies
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Coverage of major trends and challenges that affect the market and the supplier landscape
- End-use industry coverage, including hospitals and diagnostic laboratories, and research institutes
- Evaluation of the market's dynamics, including growth drivers and restraints
- Company profiles of major players in the market, including Abbott Laboratories, Abcam, Abnova, Danaher Corp. and PeproTech GmbH"
The report provides an analysis based on each market segment which includes products, applications and end users. The product segment is further sub-segmented into IHC antibodies, reagents, kits and equipment. The antibodies held the largest market share of xx in 2017 in terms of revenue followed by reagents, equipment and kits. By 2022, total revenue from the antibodies segment is expected toreach more than xx. Whereas, the reagents segment is estimated to rise at the highest CAGR of xx through 2022. Total revenue from the reagents segment is expected to reach xx million by 2022."
"Report Scope
The scope of this market report is widely characterized by products that include antibodies, equipment, kits and reagents. The total market revenue is restricted to the revenues obtained from the sales of the products required to perform IHC testing successfully. This report covers the different applications of immunohistochemistry in drugs and diagnostics.
Report Includes
- 56 data tables and 65 additional tables
- An overview of the global markets and expected consumption for immunohistochemistry (IHC) technologies
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Coverage of major trends and challenges that affect the market and the supplier landscape
- End-use industry coverage, including hospitals and diagnostic laboratories, and research institutes
- Evaluation of the market's dynamics, including growth drivers and restraints
- Company profiles of major players in the market, including Abbott Laboratories, Abcam, Abnova, Danaher Corp. and PeproTech GmbH"
Continue.....
– More
Clear Details get Full Table of Contents_
https://www.researchmoz.us/immunohistochemistry-ihc-global-markets-to-2022-report.html/toc
About
Researchmoz,
ResearchMoz
is the world’s fastest growing collection of market research
reports worldwide. Our database is composed of current market studies
from over 100 featured publishers worldwide. Our market research
databases integrate statistics with analysis from global, regional,
country and company perspectives. ResearchMoz’s service portfolio
also includes value-added services such as market research
customization, competitive landscaping, and in-depth surveys,
delivered by a team of experienced Research
Coordinators.
--Researchmoz Global Pvt. Ltd.--
--Researchmoz Global Pvt. Ltd.--
Mr.
Nachiket G.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
Comments
Post a Comment